Videos

“Our main finding was that participants who reported food insecurity in the past year were 65%, more likely to experience urge incontinence compared to those who were food secure,” says Chihiro Okada.

Researchers identify association between food insecurity and urge incontinence

Articles

Patients in the study had tumors that were not completely resectable.

Tislelizumab plus nab-paclitaxel shows promise in high-risk NMIBC

The investigators concluded that a phase 3 trial is warranted.

Study shows QoL sustained with mitomycin gel in low-grade NMIBC

In the PADRES trial, neoadjuvant axitinib facilitated partial nephrectomy in patients with clear cell renal cell carcinoma and complex masses with an imperative indication for nephron-sparing surgery but no viable pathway to receive the procedure.

Results of phase 3 PADRES trial of neoadjuvant axitinib in renal cell carcinoma

“We found that men with an elevated FSH but a normal semen test were more likely to have a decline in their sperm concentration and their total motile sperm count over time…when compared to men also starting with the normal semen test but with a normal FSH,” says Joshua Halpern, MD.

Elevated FSH is associated with decline in sperm concentration

“It’s an exciting time in UTUC,” says Joseph Jacob, MD.

Dr. Joseph Jacob on the future of nonsurgical treatment in UTUC

“A ureteral stent can be bothersome, but it’s quite variable. Some people don’t even feel the stent and some people have severe symptoms,” says Johnathan Harper, MD.

Dr. Harper on risk factors for increased stent-associated symptoms after ureteroscopy for stones

Investigators reported that all responders had FGFR3 mutations and that most non-responders had a prior history of bladder cancer, with 1 patient having a FGFR3-TACC3 fusion. 

Infigratinib associated with tumor reduction in patients with localized upper tract urothelial carcinoma

“These findings are hypothesis-generating and suggest a possible therapeutically synergistic role for immune checkpoint blockade in [patients with] BCG-unresponsive NMIBC who may have partial or short-term response to nadofaragene treatment,” said lead study author Anirban P. Mitra, MD, PhD.

Nadofaragene firadenovec, PD-1 inhibitors show synergistic activity in bladder cancer

“[Mitomycin gel] is efficacious as a [chemoablation] agent in adult patients with low-grade upper tract urothelial cancer, and while it’s FDA approved for both antegrade and retrograde administration, prior reports are limited to the retrograde experience,” said study investigator Kyle Rose, MD.

AUA